Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Watson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cell Reports|June 27, 2019
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver MetastasisBrian E Hsu, Sébastien Tabariès, Radia M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant MelanomasMatthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
Nature Cancer|May 22, 2025
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancerAnca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Nature|February 1, 2023
Single-cell spatial immune landscapes of primary and metastatic brain tumoursElham Karimi, Miranda W Yu, Sarah M Maritan, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cell Reports|June 27, 2019
Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver MetastasisBrian E Hsu, Sébastien Tabariès, Radia M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant MelanomasMatthew Dankner, Mathieu Lajoie, Dan Moldoveanu, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.
Breast Cancer Research : BCR|January 17, 2020
p66ShcA functions as a contextual promoter of breast cancer metastasisKyle Lewis, Alex Kiepas, Jesse Hudson, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
Nature Cancer|May 22, 2025
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancerAnca Apavaloaei, Qingchuan Zhao, Leslie Hesnard, et al.
Cell Reports|March 2, 2025
The NF1 tumor suppressor regulates PD-L1 and immune evasion in melanomaDiana Berry, Dan Moldoveanu, Shivshankari Rajkumar, et al.
Nature|February 1, 2023
Single-cell spatial immune landscapes of primary and metastatic brain tumoursElham Karimi, Miranda W Yu, Sarah M Maritan, et al.
Pageof 4